跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BRIVARACETAM SWANPOND INVESTMENTS 75 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
BRIVARACETAM SWANPOND INVESTMENTS 75 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
BRIVARACETAM SWANPOND INVESTMENTS 75 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Swan Pond Investments Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 8, 2025
Approval ID
b16fa744c0653f6c
Company
Swan Pond Investments Limited
Type
Standard
Approval Details
Approval Id
b16fa744c0653f6c
Drug Cima Aemps Name
BRIVARACETAM SWANPOND INVESTMENTS 75 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
90657
Holder Company Name
Swan Pond Investments Limited
Marketing Company Name
Swan Pond Investments Limited
Authorization Date
2025-10-08
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
75 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Swan Pond Investments Limited
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 8, 2025
Approval ID
b16fa744c0653f6c
Type
Standard
Back to CIMA-AEMPS Approvals